TRIOXBIO
TrioxBio is a clinical-stage biotech company specializes in the development and commercialization of proprietary synthetic small molecules to treat diseases and medical conditions related to the pathological overproduction of Nitric Oxide (NO). With this, TrioxBio can provide patients with better access to high-quality, cost-effective medicines in key therapeutic areas.
TRIOXBIO
Industry:
Biotechnology Health Care Medical
Founded:
2015-05-01
Address:
Ramat Gan, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.trioxbio.com
Total Employee:
1+
Status:
Active
Contact:
+972-3-6114543
Technology used in webpage:
Domain Not Resolving Iomart
Similar Organizations
AQTIS Medical
Sinclair company, specializes in the research, development, manufacturing and commercialization of innovative injectable medical devices.
Bio-gen Extracts
Bio-gen Extracts specializes in the development and production of scientifically-backed health ingredients.
CanSino Biologics
CanSino Biologics focuses on the R&D, manufacturing, and commercialization of vaccine products for human use.
Euchloe Bio
Euchloe Bio specializes in the discovery, development, engineering and commercialization of novel, fully-human antibodies.
NasasBiotech
Biomedicine start-up developing and commercializing metastatic tumor cells capturing devices.
Regenero
Regenero specializes in the development and commercialization of innovative cellular therapies.
Rusan Pharma
Rusan Pharma specializes in the research, development, and marketing of various narcotics and psychotropic drugs.
Sanare Bioscience
Sanare Bioscience specializes in the development and commercialization of medical products that improve patient outcomes.
Current Employees Featured
Shlomo Sadoun Founder and CEO @ TrioxBio
Founder and CEO
Founder
Official Site Inspections
http://www.trioxbio.com
- Host name: daisy.specialservers.com
- IP address: 5.77.41.163
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "TrioxBio"
TrioxBio - Crunchbase Company Profile & Funding
TrioxBio is a clinical-stage biotech company specializes in the development and commercialization of proprietary synthetic small molecules to treat diseases …See details»
TrioxBio - LinkedIn
TrioxBio's API, S-ethylisothiouronium diethylphosphate, MTR-104, is a Nitric Oxide Synthase (NOS) inhibitor which blocks the production of nitric oxide, preventing the dilation of blood …See details»
Triox Bio Company Profile | Management and Employees List
TrioxBio Inc. is a clinical-stage biopharmaceutical company specializing in the development of compounds to treat diseases and medical conditions related to the pathological overproduction …See details»
TrioxBio - VentureRadar
TrioxBio Inc. is a clinical-stage biotech company specializing in the development of compounds to treat diseases and medical conditions related to the pathological overproduction of Nitric Oxide …See details»
TrioxBio - Israeli Startup | Startup Nation Finder
TrioxBio develops and commercializes proprietary synthetic small molecules to treat pathologic states caused by the overproduction of nitric oxide. The company's API, S-ethylisothiouronium …See details»
TrioxBio - Contacts, Employees, Board Members, Advisors & Alumni
TrioxBio specializes in the development and commercialization of proprietary synthetic small molecules.See details»
S-ethylisothiourea diethylphosphate – CheckOrphan
Aug 29, 2016 TrioxBio, Inc.;P. O. Box 1000;Wilmington, Delaware, 19801 About CheckOrphan. CheckOrphan is a non-profit organization located in Basel, Switzerland and Santa Cruz, …See details»
Investor Relations – TrioxBio
The CEO of TrioxBio is the founder and former CEO of the SK- Pharma Group, a global pharmaceutical company that manufactures, sells and markets generic pharmaceutical …See details»
Euchloe Bio - Crunchbase
Euchloe Bio, TrioxBio, Ardent Pharmaceuticals, and Emmaus Medical Japan operate in the biotechnology and pharmaceutical sector. Euchloe Bio focuses on fully-human antibodies, …See details»
Q&A with Shlomo Sadoun, CEO of TrioxBio Inc. developing their …
TrioxBio Inc. www.trioxbio.com Contact: Shlomo Sadoun Shlomo@trioxbio.com Chief Executive Officer TrioxBio. Inc Moshe Aviv Tower, 35th floor Jabotinsky 7 Ramat Gan Israel 5252007 …See details»
Top 24 Notable Biotechnology Firms in Delaware - Inven
Adesis, Inc. is a contract research organization specializing in custom molecular synthesis, research and development, and specialty manufacturing. ... TrioxBio is a Delaware-based …See details»
Triox Bio - Overview, News & Similar companies | ZoomInfo.com
Who is Triox Bio. TrioxBio Inc. is a clinical-stage biopharmaceutical company specializing in the development of compounds to treat diseases and medical conditions r elated to the …See details»
MTR-108 – TrioxBio
There is no doubt that experiencing excruciating pain that doesn't go away, no matter what, is a far more serious matter than onlookers may think. It is our fervent hope that TrioxBio's …See details»
TrioxBio - Similar Companies | Startup Nation Finder
Find out more about TrioxBio's similar companies.See details»
TrioxBio - YouTube
Share your videos with friends, family, and the worldSee details»
Home [tridixbio.com]
TriDix Bio. Special Offer For New Customers 15% off New Customers with Coupon Code NEW15 at Checkout Shop Now !See details»
Trisk Bio - Home
Info@triskbio.com © 2024 Trisk Bio Ltd. All rights reserved. Unit 5 Gunnels Wood Park, Stevenage, SG1 2BH, United Kingdom Company Number: 12699023 - VAT Registration ...See details»
Trilobio - Crunchbase Company Profile & Funding
Trilobio was created to improve synthetic biology and life science research processes by building robotic lab automation modules coupled with an "app store" to package and distribute lab …See details»
Blood test developed to allow early detection of multiple cancers
Jan 14, 2025 Researchers at the University of Oxford have unveiled a new blood test – powered by machine learning – which shows real promise in detecting multiple types of cancer in their …See details»
Treos Bio
Treos Bio is a clinical stage company developing next generation of effective off-the-shelf peptide cancer vaccines based on a novel perspective on how HLA genes influence immune …See details»